SCHEMBL6430831

SCHEMBL6430831

COc1cc2nccc(Nc3ccc(Cl)cc3F)c2cc1OCCCN1CCOCC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 12/20 0.78
KDR P35968 10/20 0.78
FGFR1 P11362 9/20 0.78
FLT1 P17948 9/20 0.78
FLT4 P35916 6/20 0.78
SRC P12931 3/20 0.61
AXL P30530 2/20 0.61
ERBB2 P04626 2/20 0.61
CIT O14578 1/20 0.61
GAK O14976 1/20 0.61
EPHB6 O15197 1/20 0.61
ABCC4 O15439 1/20 0.61
DAPK3 O43293 1/20 0.61
RIPK2 O43353 1/20 0.61
NR1I2 O75469 1/20 0.61
RPS6KA4 O75676 1/20 0.61
STK17B O94768 1/20 0.61
STK10 O94804 1/20 0.61
PRKD3 O94806 1/20 0.61
ABCB11 O95342 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6431410 1.00 EGFR (0.78) EGFRKDRFGFR1FLT1FLT4
Hydrochloric Acid SCHEMBL6882131 0.99 EGFR (0.77) EGFRKDRFGFR1FLT1FLT4
SCHEMBL6430749 0.92 FGFR1 (0.75) EGFRKDRFGFR1FLT1FLT4
Hydrochloric Acid SCHEMBL6434695 0.91 FGFR1 (0.77) EGFRKDRFGFR1FLT1FLT4
SCHEMBL12469296 0.90 AXL (0.73) EGFRKDRFGFR1FLT1FLT4
Hydrochloric Acid SCHEMBL6098444 0.88 KDR (0.72) EGFRKDRFGFR1FLT1FLT4
SCHEMBL6431449 0.88 FLT1 (0.71) EGFRKDRFGFR1FLT1FLT4
SCHEMBL12308286 0.87 EGFR (0.77) EGFRKDRFGFR1FLT1FLT4
SCHEMBL7857964 0.87 KDR (1.00) EGFRKDRFGFR1FLT1FLT4
SCHEMBL900298 0.87 AXL (0.69) EGFRKDRFGFR1FLT1FLT4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6809097-B1 ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY ZENECA LIMITED (GB) 2004-10-26 US claimed
EP-0929526-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1999-07-21 EP claimed
WO-1998013350-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1998-04-02 WO claimed
EP-0929526-B1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ASTRAZENECA AB (SE) 2005-07-27 EP disclosed
US-6809097-B1 ANTIANGIOGENIC AND/OR VASCULAR PERMEABILITY ZENECA LIMITED (GB) 2004-10-26 US disclosed
EP-0929526-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1999-07-21 EP disclosed
WO-1998013350-A1 QINOLINE DERIVATIVES INHIBITING THE EFFECT OF GROWTH FACTORS SUCH AS VEGF ZENECA LIMITED (GB) 1998-04-02 WO disclosed